Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Prostatic Neoplasms 42 Uterine Cervical Neoplasms 41 Breast Neoplasms 10 Vaginal Neoplasms 6 Neoplasms 6 Endometrial Neoplasms 6 Liver Neoplasms 5 Uterine Neoplasms 4 Sarcoma 4 Lung Neoplasms 4 Esophageal Neoplasms 4 Vulvar Neoplasms 3 Retinoblastoma 3 Radiation Injuries 3 Ovarian Neoplasms 3 Hyperthermia 3 Carcinoma, Hepatocellular 3 Adenocarcinoma 3 Rhabdomyosarcoma 2 Rectal Neoplasms 2 Melanoma 2 Head and Neck Neoplasms 2 Gynecologic Cancer 2 Desmoplastic Small Round Cell Tumor 2 Deglutition Disorders 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Intraductal, Noninfiltrating 2 Carcinoma, Ductal, Breast 2 Breast Carcinoma In Situ 2 Uveal Melanoma 1

Interventions

Radiotherapy 3 Radiation 3 Radiotherapy, Intensity-Modulated 2 Fluorouracil 2 Cisplatin 2 toripalimab 1 rocakinogene sifuplasmid 1 pembrolizumab 1 durvalumab 1 atezolizumab 1 Vaccines 1 VGX-3100 1 Radiosurgery 1 Neoadjuvant Therapy 1 Mitomycins 1 Magnetic Resonance Spectroscopy 1 MEDI0457 1 Immunoglobulin G 1 Immune Checkpoint Inhibitors 1 Docetaxel 1 Disulfides 1 Chemoradiotherapy 1 Capecitabine 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Anal Canal Carcinoma × Brachytherapy × Clear all

NCT03465501 2018-03-14

BOOST-CA

Institut Paoli-Calmettes

Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡